Publications by authors named "Stephen B Ting"

Claim this Profile
R
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Stephen B Ting

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avascular necrosis in older adolescents and adults with acute lymphoblastic leukemia treated with FRALLE protocols: a multicenter analysis of incidence, risk factors and morbidity.
Michelle Tan, Masa Lasica, Vanessa Donati, Kirsty Rady, Meena Nagarethinam, Stephen B Ting

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to venetoclax in patients with blastic plasmacytoid dendritic cell neoplasm.
Kirsty M Sharplin, Catherine Vassiliou, James Nguyen, Bryone J Kuss, Stephen B Ting

Leuk Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).
Chong Chyn Chua, Sun Loo, Chun Yew Fong, Stephen B Ting, Ing Soo Tiong

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehabilitation to improve function after autologous stem cell transplantation: A pilot randomized controlled trial (PIRATE).
Amy M Dennett, Judi Porter, Stephen B Ting, Nicholas F Taylor

Support Care Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing S Tiong, Chong Chyn Chua, Stephen B Ting

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Sun Loo, Andrew W Roberts, Natasha S Anstee, Glen A Kennedy, Simon He, Stephen B Ting

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry.
Lucy C Fox, Zoe K McQuilten, Frank Firkin, Vanessa Fox, Xavier Badoux, Stephen B Ting

Best Pract Res Clin Haematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased STAT expression in Reed-Sternberg cells as a potential positive prognostication biomarker in Hodgkin lymphoma.
Ahmad Zargari, Katherine D Cummins, Patrick Hosking, Alan Pham, Eliza Hawkes, Stephen B Ting

Pathology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehabilitation to improve outcomes afteR Autologous sTem cEll transplantation (PIRATE): A pilot randomised controlled trial protocol.
Amy M Dennett, Judi Porter, Stephen B Ting, Nicholas F Taylor

PLoS One· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Stephen B Ting

Blood· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia.
Halina H L Leung, Jose Perdomo, Zohra Ahmadi, Shiying S Zheng, Fairooj N Rashid, Stephen B Ting

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shutting the gate: targeting endocytosis in acute leukemia.
Cedric S Tremblay, Stephen B Ting, Adam McCluskey, Phillip J Robinson, David J Curtis

Exp Hematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the gap: a pre-post feasibility study of embedding exercise therapy into a co-located cancer unit.
Amy M Dennett, Bernadette Zappa, Rachel Wong, Stephen B Ting, Kimberley Williams

Support Care Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150).
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Stephen B Ting

Blood Cancer J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Stephen B Ting

Blood Cancer J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first known case of vaccine-induced thrombotic thrombocytopenia in Australia.
Jay Hocking, Sanjeev D Chunilal, Vivien M Chen, Tim Brighton, James Nguyen, Stephen B Ting

Med J Aust· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budgeting at the Ca store: a PIPeline to starve LSCs?
Giovanni Monaco, Stefano Percio, Stephen B Ting

Cell Calcium· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.
Chong Chyn Chua, Andrew W Roberts, John Reynolds, Chun Yew Fong, Stephen B Ting

J Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.
Lucy C Fox, Michelle Tan, Anna L Brown, Peer Arts, Ella Thompson, Stephen B Ting

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment practice and outcomes in mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals.
Chong C Chua, Andrew Grigg, Jasmine Singh, Mark P Droogleever, Lan Zhang, Stephen B Ting

Leuk Lymphoma· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Ap2a2 in PPARα-mediated regulation of lipolysis in adipose tissue.
Magdalene K Montgomery, Jacqueline Bayliss, Stacey Keenan, Sarah Rhost, Stephen B Ting

FASEB J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated Acceleration to Leukemia after Ezh2 Loss in Nup98-HoxD13 (NHD13) Myelodysplastic Syndrome.
Victoria Y Ling, Jesslyn Saw, Cedric S Tremblay, Stefan E Sonderegger, Emma Toulmin, Stephen B Ting

Hemasphere· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.
Miriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, Michal Abrahamowicz, Coraline Danieli, Stephen B Ting

Blood Cancer J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cells.
Cedric S Tremblay, Jesslyn Saw, Sung Kai Chiu, Nicholas C Wong, Kirill Tsyganov, Stephen B Ting

Nat Commun· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis